A dimeric dipeptide mimetic of brain-derived neurotrophic factor loop 2, bis-(N-hexanoyl-seryl-lysine) hexamethylenediamide or GTS-201, was designed and synthesized. It exhibited neuroprotective activity at concentrations of 10–5 – 10–8 M in HT-22 immortalized hippocampal neuronal cell culture under H2O2-induced oxidative stress. Western-blot analysis showed that it activated TrkB receptors and Erk but not Akt. GTS-201 did not exhibit antidepressant activity in a Porsolt forced swim test on BALB/c mice at i.p. doses of 0.1, 1.0, and 5.0 mg/kg, in contrast with previously synthesized GSB-106, a dimeric dipeptide mimetic of loop 4. The results confirmed the previous original hypothesis about the possible discrimination of neurotrophin functions by low-molecular-mass mimetics of their separate loops.
Similar content being viewed by others
References
M. C. Cardenas-Aguayo, S. F. Kazim, I. Grundke-Iqbal, and K. Iqbal, PLoS One, 8(1), 1 – 18 (2013).
C. Zuccato and E. Cattaneo, Nat. Rev. Neurol., 5, 311 – 322 (2009).
H. Yu and Z. Chen, Acta Pharmacol. Sin., 32, 3 – 11 (2011).
J. Adlam and R. Zaman, Psychiatr. Danubina, 25(2), 368 – 369 (2013).
B. C. Monteiro, S. Monteiro, M. Candida, et al., Clin. Pract. Epidemiol. Ment. Health, 13, 213 – 219 (2017).
T. A. Gudasheva, T. A. Antipova, and S. B. Seredenin, Dokl. Akad. Nauk, 434(4), 549 – 552 (2010).
S. B. Seredenin and T. A. Gudasheva, RU Pat. 2,410,392, Aug. 27, 2010; Byull. Izobret., 3 (2011).
T. A. Gudasheva, Izv. Akad. Nauk, Ser. Khim., 9, 2012 – 2021 (2015).
T. A. Gudasheva, A. V. Tarasyuk, S. V. Pomogaibo, et al., Bioorg. Khim., 38(3), 280 – 290 (2012).
S. B. Seredenin, T. A. Voronina, T. A. Gudasheva, et al., Acta Nat., 5(4), (19), 116 – 120 (2013).
R. U. Ostrovskaya, S. S. Yagubova, T. A. Gudasheva, and S. B. Seredenin, Byull. Eksp. Biol. Med., 164(12), 701 – 705 (2017).
A. Paquet, Can. J. Chem., 60, 976 – 980 (1982).
L. T. Kisfaludy, J. E. Roberts, R. H. Johnson, et al., J. Org. Chem., 35(10), 3563 – 3564 (1970).
G. R. Jackson, K. Werrbach-Perez, E. L. Ezell, et al., Brain Res., 592(1), 239 – 248 (1992).
R. D. Porsolt, A. Bertin, and M. Jalfre, Eur. J. Pharmacol., 51, 291 – 294 (1978).
N. M. Sazonova, A. V. Tarasyuk, D. V. Kurilov, et al., Khim.-farm. Zh., 49(7), 10 – 19 (2015); Pharm. Chem. J., 49(7), 439 – 448 (2015).
M. Jaouadi, J. Martinez, and B. Castro, J. Org. Chem., 52, 2364 – 2367 (1987).
Y. Ueda, E. Walsh, H. Nakanishi, and K. Yoshida, Neurosci. Lett., 165(1 – 2), 203 – 207 (1994).
S. M. Massa, T. Yang, Y. Xie, et al., J. Clin. Invest., 120(5), 1774 – 1785 (2010).
J. Cassani, A. M. Dorantes-Barron, L. M. Novales, et al., Molecules, 19(12), 21442 – 21461 (2014).
Acknowledgments
The work was sponsored by the Russian Science Foundation (Project No. 18-15-00381).
Author information
Authors and Affiliations
Corresponding author
Additional information
** Published in part as academic theses; T. A. Gudasheva et al., Dokl. Akad. Nauk, 476(1), 108 – 112 (2017).
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 52, No. 9, pp. 14 – 21, September, 2018.
Rights and permissions
About this article
Cite this article
Sazonova, N.M., Tarasyuk, A.V., Shumskii, A.N. et al. Synthesis and Biological Properties of a New Dipeptide Mimetic of Brain-Derived Neurotrophic Factor Loop 2**. Pharm Chem J 52, 763–770 (2018). https://doi.org/10.1007/s11094-018-1896-0
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-018-1896-0